These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Correlation between outer retinal layer thickness and cone density in patients with resolved central serous chorioretinopathy. Nakamura T, Ueda-Consolvo T, Oiwake T, Hayashi A. Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2347-2354. PubMed ID: 27255458 [Abstract] [Full Text] [Related]
12. Three-dimensional configuration of subretinal fluid in central serous chorioretinopathy. Ahn SE, Oh J, Oh JH, Oh IK, Kim SW, Huh K. Invest Ophthalmol Vis Sci; 2013 Sep 03; 54(9):5944-52. PubMed ID: 23920371 [Abstract] [Full Text] [Related]
13. A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the CONTAIN study. Pitcher JD, Witkin AJ, DeCroos FC, Ho AC. Br J Ophthalmol; 2015 Jun 03; 99(6):848-52. PubMed ID: 25595177 [Abstract] [Full Text] [Related]
19. A 50% vs 30% dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trial. Zhao M, Zhang F, Chen Y, Dai H, Qu J, Dong C, Kang X, Liu Y, Yang L, Li Y, Zhou P, Pan CT, Zhang L, Liu P, Zhou H, Jiao X, Xiong Y, Tian R, Lu Y, Yu X, Li X. JAMA Ophthalmol; 2015 Mar 03; 133(3):333-40. PubMed ID: 25555191 [Abstract] [Full Text] [Related]
20. Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial. Bae SH, Heo J, Kim C, Kim TW, Shin JY, Lee JY, Song SJ, Park TK, Moon SW, Chung H. Ophthalmology; 2014 Feb 03; 121(2):558-65. PubMed ID: 24268858 [Abstract] [Full Text] [Related] Page: [Next] [New Search]